List of Tables
Table 1. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Others
Table 6. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Longevity and Anti-senescence Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Longevity and Anti-senescence Therapy Market Share by Region (2019-2024)
Table 10. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Longevity and Anti-senescence Therapy Market Share by Region (2025-2030)
Table 12. Longevity and Anti-senescence Therapy Market Trends
Table 13. Longevity and Anti-senescence Therapy Market Drivers
Table 14. Longevity and Anti-senescence Therapy Market Challenges
Table 15. Longevity and Anti-senescence Therapy Market Restraints
Table 16. Global Longevity and Anti-senescence Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Longevity and Anti-senescence Therapy Revenue Share by Players (2019-2024)
Table 18. Global Top Longevity and Anti-senescence Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-senescence Therapy as of 2023)
Table 19. Global Longevity and Anti-senescence Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Longevity and Anti-senescence Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Longevity and Anti-senescence Therapy, Headquarters and Area Served
Table 22. Global Key Players of Longevity and Anti-senescence Therapy, Product and Application
Table 23. Global Key Players of Longevity and Anti-senescence Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Longevity and Anti-senescence Therapy Revenue Share by Application (2019-2024)
Table 31. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Longevity and Anti-senescence Therapy Revenue Share by Application (2025-2030)
Table 33. North America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Longevity and Anti-senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Longevity and Anti-senescence Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 65. Bristol Myers Squibb Company Details
Table 66. Bristol Myers Squibb Business Overview
Table 67. Bristol Myers Squibb Longevity and Anti-senescence Therapy Product
Table 68. Bristol Myers Squibb Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 69. Bristol Myers Squibb Recent Developments
Table 70. CohBar Company Details
Table 71. CohBar Business Overview
Table 72. CohBar Longevity and Anti-senescence Therapy Product
Table 73. CohBar Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 74. CohBar Recent Developments
Table 75. Life Biosciences Company Details
Table 76. Life Biosciences Business Overview
Table 77. Life Biosciences Longevity and Anti-senescence Therapy Product
Table 78. Life Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 79. Life Biosciences Recent Developments
Table 80. AgeX Therapeutics Company Details
Table 81. AgeX Therapeutics Business Overview
Table 82. AgeX Therapeutics Longevity and Anti-senescence Therapy Product
Table 83. AgeX Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 84. AgeX Therapeutics Recent Developments
Table 85. Unity Biotechnology Company Details
Table 86. Unity Biotechnology Business Overview
Table 87. Unity Biotechnology Longevity and Anti-senescence Therapy Product
Table 88. Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 89. Unity Biotechnology Recent Developments
Table 90. Calico Life Sciences Company Details
Table 91. Calico Life Sciences Business Overview
Table 92. Calico Life Sciences Longevity and Anti-senescence Therapy Product
Table 93. Calico Life Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 94. Calico Life Sciences Recent Developments
Table 95. Oisin Biotechnologies Company Details
Table 96. Oisin Biotechnologies Business Overview
Table 97. Oisin Biotechnologies Longevity and Anti-senescence Therapy Product
Table 98. Oisin Biotechnologies Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 99. Oisin Biotechnologies Recent Developments
Table 100. T.A. Sciences Company Details
Table 101. T.A. Sciences Business Overview
Table 102. T.A. Sciences Longevity and Anti-senescence Therapy Product
Table 103. T.A. Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 104. T.A. Sciences Recent Developments
Table 105. BioAge Labs Company Details
Table 106. BioAge Labs Business Overview
Table 107. BioAge Labs Longevity and Anti-senescence Therapy Product
Table 108. BioAge Labs Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 109. BioAge Labs Recent Developments
Table 110. Retro Biosciences Company Details
Table 111. Retro Biosciences Business Overview
Table 112. Retro Biosciences Longevity and Anti-senescence Therapy Product
Table 113. Retro Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 114. Retro Biosciences Recent Developments
Table 115. Senolytic Therapeutics Company Details
Table 116. Senolytic Therapeutics Business Overview
Table 117. Senolytic Therapeutics Longevity and Anti-senescence Therapy Product
Table 118. Senolytic Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024) & (US$ Million)
Table 119. Senolytic Therapeutics Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Longevity and Anti-senescence Therapy Market Share by Type: 2023 VS 2030
Figure 3. Drug Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Others Features
Figure 7. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Longevity and Anti-senescence Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Medical Service Institution Case Studies
Figure 11. Others Case Studies
Figure 12. Longevity and Anti-senescence Therapy Report Years Considered
Figure 13. Global Longevity and Anti-senescence Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Longevity and Anti-senescence Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Longevity and Anti-senescence Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Longevity and Anti-senescence Therapy Market Share by Players in 2023
Figure 17. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-senescence Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2023
Figure 19. North America Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 21. North America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 22. North America Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 23. United States Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 27. Europe Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 28. Europe Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 29. Germany Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 37. China Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 38. Asia Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 40. Asia Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 41. Asia Longevity and Anti-senescence Therapy Market Share by Region (2019-2030)
Figure 42. Japan Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Longevity and Anti-senescence Therapy Market Share by Country (2019-2030)
Figure 52. Brazil Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Longevity and Anti-senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 59. CohBar Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 60. Life Biosciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 61. AgeX Therapeutics Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 62. Unity Biotechnology Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 63. Calico Life Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 64. Oisin Biotechnologies Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 65. T.A. Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 66. BioAge Labs Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 67. Retro Biosciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 68. Senolytic Therapeutics Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
